The BBI Group was established in 1986 with only 10 staff…
And had a turnover of less than £1 Million.
BBI achieved an MBO.
BBI achieved an IPO.
Growth continues through the product and service, acquisitions and new entities.
The BBI Group was sold to Alere for £85m. Alere are a global POC leader.
We rebranded to bring our complete offering together as BBI Solutions.
The BBI Group became an independent company following an the acquisition by Exponent Private Equity.
BBI Solutions acquired Novarum DX Ltd.
Invested £14m in the new BBI Group Global Headquarters.
April 2020, BBI Group joins the UK Rapid Test Consortium to rapidly develop and rollout the Coronavirus tests.
June 2020, BBI Group acquires DIARECT AG, establishing BBI as the leading provider of antigens in the autoimmune and tick-borne IVD markets
Aquisition of BBI group by Novo Holdings
January 2022 aquisition of Biotez GmbH and Steffens Biotechnische Analysen GmbH